These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

293 related items for PubMed ID: 18258820

  • 1. Evaluation of matrix metalloproteinases in atherosclerosis using a novel noninvasive imaging approach.
    Lancelot E, Amirbekian V, Brigger I, Raynaud JS, Ballet S, David C, Rousseaux O, Le Greneur S, Port M, Lijnen HR, Bruneval P, Michel JB, Ouimet T, Roques B, Amirbekian S, Hyafil F, Vucic E, Aguinaldo JG, Corot C, Fayad ZA.
    Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):425-32. PubMed ID: 18258820
    [Abstract] [Full Text] [Related]

  • 2. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
    Ouimet T, Lancelot E, Hyafil F, Rienzo M, Deux F, Lemaître M, Duquesnoy S, Garot J, Roques BP, Michel JB, Corot C, Ballet S.
    Mol Pharm; 2012 Apr 02; 9(4):850-61. PubMed ID: 22352457
    [Abstract] [Full Text] [Related]

  • 3. Atherosclerosis and matrix metalloproteinases: experimental molecular MR imaging in vivo.
    Amirbekian V, Aguinaldo JG, Amirbekian S, Hyafil F, Vucic E, Sirol M, Weinreb DB, Le Greneur S, Lancelot E, Corot C, Fisher EA, Galis ZS, Fayad ZA.
    Radiology; 2009 May 02; 251(2):429-38. PubMed ID: 19224894
    [Abstract] [Full Text] [Related]

  • 4. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
    Yasuda S, Ikuta K, Uwatoku T, Oi K, Abe K, Hyodo F, Yoshimitsu K, Sugimura K, Utsumi H, Katayama Y, Shimokawa H.
    J Vasc Res; 2008 May 02; 45(2):123-8. PubMed ID: 17940339
    [Abstract] [Full Text] [Related]

  • 5. Noninvasive imaging of atherosclerotic vessels by MRI for clinical assessment of the effectiveness of therapy.
    Corti R.
    Pharmacol Ther; 2006 Apr 02; 110(1):57-70. PubMed ID: 16445985
    [Abstract] [Full Text] [Related]

  • 6. Peptidic targeting of phosphatidylserine for the MRI detection of apoptosis in atherosclerotic plaques.
    Burtea C, Laurent S, Lancelot E, Ballet S, Murariu O, Rousseaux O, Port M, Vander Elst L, Corot C, Muller RN.
    Mol Pharm; 2009 Apr 02; 6(6):1903-19. PubMed ID: 19743879
    [Abstract] [Full Text] [Related]

  • 7. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A, Krämer SD, Meletta R, Beck K, Selivanova SV, Rancic Z, Kaufmann PA, Vos B, Meding J, Stellfeld T, Heinrich TK, Bauser M, Hütter J, Dinkelborg LM, Schibli R, Ametamey SM.
    Nucl Med Biol; 2014 Aug 02; 41(7):562-9. PubMed ID: 24853402
    [Abstract] [Full Text] [Related]

  • 8. Molecular imaging of alpha v beta3 integrin expression in atherosclerotic plaques with a mimetic of RGD peptide grafted to Gd-DTPA.
    Burtea C, Laurent S, Murariu O, Rattat D, Toubeau G, Verbruggen A, Vansthertem D, Vander Elst L, Muller RN.
    Cardiovasc Res; 2008 Apr 01; 78(1):148-57. PubMed ID: 18174291
    [Abstract] [Full Text] [Related]

  • 9. Quantitation and localization of matrix metalloproteinases and their inhibitors in human carotid endarterectomy tissues.
    Choudhary S, Higgins CL, Chen IY, Reardon M, Lawrie G, Vick GW, Karmonik C, Via DP, Morrisett JD.
    Arterioscler Thromb Vasc Biol; 2006 Oct 01; 26(10):2351-8. PubMed ID: 16888239
    [Abstract] [Full Text] [Related]

  • 10. Divergent effects of matrix metalloproteinases 3, 7, 9, and 12 on atherosclerotic plaque stability in mouse brachiocephalic arteries.
    Johnson JL, George SJ, Newby AC, Jackson CL.
    Proc Natl Acad Sci U S A; 2005 Oct 25; 102(43):15575-80. PubMed ID: 16221765
    [Abstract] [Full Text] [Related]

  • 11. Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability.
    Johnson JL.
    Expert Rev Cardiovasc Ther; 2007 Mar 25; 5(2):265-82. PubMed ID: 17338671
    [Abstract] [Full Text] [Related]

  • 12. Monitoring of arterial wall remodelling in atherosclerotic rabbits with a magnetic resonance imaging contrast agent binding to matrix metalloproteinases.
    Hyafil F, Vucic E, Cornily JC, Sharma R, Amirbekian V, Blackwell F, Lancelot E, Corot C, Fuster V, Galis ZS, Feldman LJ, Fayad ZA.
    Eur Heart J; 2011 Jun 25; 32(12):1561-71. PubMed ID: 21118852
    [Abstract] [Full Text] [Related]

  • 13. Targeted contrast agent helps to monitor advanced plaque during progression: a magnetic resonance imaging study in rabbits.
    Zheng J, Ochoa E, Misselwitz B, Yang D, El Naqa I, Woodard PK, Abendschein D.
    Invest Radiol; 2008 Jan 25; 43(1):49-55. PubMed ID: 18097277
    [Abstract] [Full Text] [Related]

  • 14. In vivo evaluation of a new magnetic resonance imaging contrast agent (P947) to target matrix metalloproteinases in expanding experimental abdominal aortic aneurysms.
    Bazeli R, Coutard M, Duport BD, Lancelot E, Corot C, Laissy JP, Letourneur D, Michel JB, Serfaty JM.
    Invest Radiol; 2010 Oct 25; 45(10):662-8. PubMed ID: 20733508
    [Abstract] [Full Text] [Related]

  • 15. Do metalloproteinases destabilize vulnerable atherosclerotic plaques?
    Newby AC.
    Curr Opin Lipidol; 2006 Oct 25; 17(5):556-61. PubMed ID: 16960505
    [Abstract] [Full Text] [Related]

  • 16. Matrix metalloproteinase-13/collagenase-3 deletion promotes collagen accumulation and organization in mouse atherosclerotic plaques.
    Deguchi JO, Aikawa E, Libby P, Vachon JR, Inada M, Krane SM, Whittaker P, Aikawa M.
    Circulation; 2005 Oct 25; 112(17):2708-15. PubMed ID: 16230484
    [Abstract] [Full Text] [Related]

  • 17. Inflammation in atherosclerosis: visualizing matrix metalloproteinase action in macrophages in vivo.
    Deguchi JO, Aikawa M, Tung CH, Aikawa E, Kim DE, Ntziachristos V, Weissleder R, Libby P.
    Circulation; 2006 Jul 04; 114(1):55-62. PubMed ID: 16801460
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging of vulnerable atherosclerotic plaques: current imaging strategies and molecular imaging probes.
    Briley-Saebo KC, Mulder WJ, Mani V, Hyafil F, Amirbekian V, Aguinaldo JG, Fisher EA, Fayad ZA.
    J Magn Reson Imaging; 2007 Sep 04; 26(3):460-79. PubMed ID: 17729343
    [Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinase-9 modulation by resident arterial cells is responsible for injury-induced accelerated atherosclerotic plaque development in apolipoprotein E-deficient mice.
    Choi ET, Collins ET, Marine LA, Uberti MG, Uchida H, Leidenfrost JE, Khan MF, Boc KP, Abendschein DR, Parks WC.
    Arterioscler Thromb Vasc Biol; 2005 May 04; 25(5):1020-5. PubMed ID: 15746435
    [Abstract] [Full Text] [Related]

  • 20. Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability.
    Johnson JL, Fritsche-Danielson R, Behrendt M, Westin-Eriksson A, Wennbo H, Herslof M, Elebring M, George SJ, McPheat WL, Jackson CL.
    Cardiovasc Res; 2006 Aug 01; 71(3):586-95. PubMed ID: 16759648
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.